Abstract
Background: This study aims to examine the productivity cost of chronic rhinosinusitis (CRS) in Australia. Secondary objective is to describe the use of Sino-Nasal Outcome Test-22 (SNOT-22) and its associated domains. Methods: In a retrospective approach, data were collected on productivity loss and SNOT-22 among 309 patients referred for management of CRS at a tertiary rhinology clinic. Productivity cost was defined via the human capital approach and monetised from the average weekly income recorded by the Australian Bureau of Statistics, May 2016. Results: CRS-related productivity cost was determined to be 37.3 work days or Australian Dollars (AUD) $10,893.84 per patient per annum. Higher productivity cost significantly correlated to higher SNOT-22 scores (P value: 0.014) and younger working age (P value: 0.005). The mean SNOT-22 score was 42.0 with no specifically worse domains. Conclusions: The estimated productivity cost of CRS provides insights and incentives for its cost-effective management.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
